Sökning: onr:"swepub:oai:DiVA.org:liu-74156" >
Long-Lasting Immune...
Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
-
- Axelsson, Stina (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Chéramy, Mikael (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Hjorth, Maria (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
visa fler...
-
- Pihl, Mikael (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Åkerman, Linda (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
- Martinuzzi, Emanuela (författare)
- St Vincent de Paul Hospital
-
- Mallone, Roberto (författare)
- St Vincent de Paul Hospital
-
- Ludvigsson, Johnny (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Pediatrik,Hälsouniversitetet,Barn- och ungdomskliniken i Linköping
-
- Casas, Rosaura (författare)
- Linköpings universitet,Pediatrik,Hälsouniversitetet
-
visa färre...
-
(creator_code:org_t)
- 2011-12-12
- 2011
- Engelska.
-
Ingår i: PLOS ONE. - : Public Library of Science. - 1932-6203. ; 6:12
- Relaterad länk:
-
https://liu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://journals.plo...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- A phase II clinical trial with glutamic acid decarboxylase (GAD) 65 formulated with aluminium hydroxide (GAD-alum) has shown efficacy in preserving residual insulin secretion in children and adolescents with recent-onset type 1 diabetes (T1D). We have performed a 4-year follow-up study of 59 of the original 70 patients to investigate long-term cellular and humoral immune responses after GAD-alum-treatment. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with GAD(65). Frequencies of naive, central and effector memory CD4+ and CD8+ T cells were measured, together with cytokine secretion, proliferation, gene expression and serum GAD(65) autoantibody (GADA) levels. We here show that GAD-alum-treated patients display increased memory T-cell frequencies and prompt T-cell activation upon in vitro stimulation with GAD(65), but not with control antigens, compared with placebo subjects. GAD(65)-induced T-cell activation was accompanied by secretion of T helper (Th) 1, Th2 and T regulatory cytokines and by induction of T-cell inhibitory pathways. Moreover, post-treatment serum GADA titres remained persistently increased in the GAD-alum arm, but did not inhibit GAD(65) enzymatic activity. In conclusion, memory T- and B-cell responses persist 4 years after GAD-alum-treatment. In parallel to a GAD(65)-induced T-cell activation, our results show induction of T-cell inhibitory pathways important for regulating the GAD(65) immunity.
Nyckelord
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
PLOS ONE
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas